This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of oral cavity, oesophagus and stomach
CD2_INSITU_ORAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ cavitatis oris, oesophagi sive ventriculi
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oral cavity, oesophagus and stomach
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 187 | 57 | 130 |
| Unadjusted period prevalence (%) | 0.05 | 0.02 | 0.06 |
| Median age at first event (years) | 69.05 | 70.30 | 68.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 169
- Matched controls
- 1689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
49.4
45
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.0
25.3
95
298
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
23.5
22
*
D00.1
ICD-10 Finland
Carcinoma in situ: Oesophagus
+∞
22.4
21
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
50.7
22.1
26
6
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
21.3
20
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
20.6
50
83
D00.00
ICD-10 Finland
Cancer in situ on the lip red border
+∞
18.0
17
*
H02AB02
ATC
dexamethasone; systemic
39.6
17.1
21
6
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
29.6
16.0
21
8
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.4
15.1
67
221
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
14.8
14
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
14.8
14
*
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
163.3
14.7
15
*
K22.7
ICD-10 Finland
Barrett oesophagus
21.5
14.6
21
11
WX402
NOMESCO Finland
General anaesthesia
6.0
14.1
41
85
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
13.7
13
*
JN4BD
NOMESCO Finland
Extensive body CT
8.4
13.5
30
42
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
43.8
13.4
16
*
N02AA05
ATC
oxycodone; systemic
5.0
13.2
46
117
WF002
NOMESCO Finland
Radical radiotherapy
+∞
12.6
12
*
D00.09
ICD-10 Finland
Unspecified cancer in situ in oral cavity and throat
+∞
12.6
12
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
139.7
12.6
13
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
14.9
12.3
20
15
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
69.8
11.8
13
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.1
11.7
20
17
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
11.6
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.6
11
*
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
128.2
11.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
128.2
11.6
12
*
UJD02
NOMESCO Finland
Gastroscopy
7.6
11.5
27
41
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
64.0
10.8
12
*
EKA10
NOMESCO Finland
Biopsy of cheek
15.6
10.7
17
12
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
15.6
10.7
17
12
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.8
10.6
21
24
WX002
NOMESCO Finland
Sedation and analgesia
3.7
10.6
53
187
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
10.5
10
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
10.5
10
*
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
+∞
10.5
10
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
10.5
10
*
R4190
NOMESCO Finland
Nutritional therapy
34.9
10.5
13
*
JN4AD
NOMESCO Finland
Body CT examination
11.1
10.3
19
19
JDB10
NOMESCO Finland
Percutaneous gastrostomy
27.9
10.0
13
5
Z51.5
ICD-10 Finland
Palliative care
12.4
9.8
17
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
32.0
9.5
12
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
9.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.5
9
*
C159, 8148, 2
ICD-O-3
NA
+∞
9.5
9
*
D00.04
ICD-10 Finland
In situ cancer of the floor of the mouth
+∞
9.5
9
*
K22.1
ICD-10 Finland
Ulcer of oesophagus
16.8
9.2
14
9
UJC12
NOMESCO Finland
Flexible oesophagoscopy
38.9
9.1
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.4
8.9
19
25
EAA10
NOMESCO Finland
Excision of lesion of lip
52.7
8.8
10
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
52.7
8.8
10
*
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
21.3
8.6
12
6
ECA20
NOMESCO Finland
Biopsy of gingiva
29.2
8.6
11
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
29.2
8.6
11
*
107
Kela drug reimbursment
Pernicious anaemia
10.2
8.5
16
17
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
+∞
8.4
8
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
+∞
8.4
8
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
13.9
8.0
13
10
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
47.1
7.8
9
*
B03BA03
ATC
hydroxocobalamin; parenteral
5.1
7.8
24
53
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
26.3
7.7
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
83.5
7.5
8
*
A04AA01
ATC
ondansetron; systemic, rectal
10.0
7.4
14
15
SBA00
NOMESCO Finland
Microbiological examinations
11.6
7.4
13
12
L57.0
ICD-10 Finland
Actinic keratosis
4.8
7.4
24
56
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
+∞
7.3
7
*
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
7.3
7
*
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
+∞
7.3
7
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
7.3
7
*
D00.01
ICD-10 Finland
In situ cancer of the mucous membrane of the cheek
+∞
7.3
7
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
7.3
7
*
TEA00
NOMESCO Finland
Biopsy of lip
16.6
7.3
11
7
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.6
6.8
23
56
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
41.7
6.8
8
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.8
6.8
29
88
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
10.6
6.6
12
12
A07AA02
ATC
nystatin; oral
5.0
6.5
20
44
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.8
6.5
27
80
K13.29
ICD-10 Finland
Indefinite leukoplakia
72.3
6.5
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
72.3
6.5
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
6.4
47
208
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
6.3
6
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
C16.00
ICD-10 Finland
Cardia
+∞
6.3
6
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
6.3
6
*
D00.05
ICD-10 Finland
In situ cancer of the pharyngeal part of the tongue
+∞
6.3
6
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
6.3
6
*
C160, 8148, 2
ICD-O-3
NA
+∞
6.3
6
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
6.3
6
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
6.3
6
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
9.1
6.2
12
14
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.2
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
38
36
12.99
36.08
1.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
43
88
6.05
21.13
1.6
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
109
5.58
21.09
2.8
2.1
g/l
0.2
0.2
0.52
48
90
(40768804) Tissue Pathology biopsy report
93
361
4.14
20.57
3.7
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
77
263
4.28
20.32
3.6
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
90
349
4.04
19.78
3.9
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
55
164
4.33
17.10
3.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
110
526
3.65
17.01
5.9
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
168
3.31
10.22
6.8
5.4
mmol/l
0.3
1.6
1.64
35
127
(3032080) INR in Blood by Coagulation assay
102
578
2.68
10.01
9.5
10.9
inr
1.1
1.4
—
10
158
(3000991) Gas panel - Venous blood
33
103
3.68
9.29
6.9
6.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
62
4.29
8.73
9.1
8.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
73
381
2.50
8.11
1.6
1.6
nmol/l
17.2
20.5
1.71
64
327
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
39
149
3.04
7.92
4.1
2.4
u/l
222.9
233.5
0.36
39
138
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
102
625
2.39
7.87
6.9
4.6
mmol/l
1.2
1.2
1.17
93
552
(3023368) Bacteria identified in Blood by Culture
74
394
2.45
7.83
6.5
3.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
48
209
2.74
7.67
2.4
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
108
688
2.35
7.50
8.1
4.9
mmol/l
1.2
1.2
1.40
96
580
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
109
3.21
7.21
6.9
5.4
mmol/l
1.7
1.4
0.30
31
103
(3006315) Basophils [#/volume] in Blood
100
627
2.28
7.08
7.1
5.1
e9/l
0.0
0.0
0.06
84
530
(3019198) Lymphocytes [#/volume] in Blood
101
638
2.27
7.00
7.2
5.1
e9/l
2.5
1.8
0.43
87
544
(3001604) Monocytes [#/volume] in Blood
99
623
2.25
6.89
7.1
5.1
e9/l
0.7
0.6
1.13
83
520
(3013650) Neutrophils [#/volume] in Blood by Automated count
106
686
2.26
6.89
12.7
6.1
e9/l
4.7
4.4
0.47
96
589
(42870588) Differential panel, method unspecified - Blood
76
429
2.30
6.87
7.1
5.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
98
3.18
6.54
1.8
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
61
3.75
6.50
8.6
7.8
mmol/l
23.8
24.9
1.07
21
50
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
7
14.99
6.47
3.0
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
15
6.99
6.37
3.4
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
369
2.27
6.33
3.3
2.2
mg/l
3.0
3.0
0.04
59
305
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
629
2.17
6.33
2.4
2.0
pmol/l
96.9
91.4
0.41
59
334
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
425
2.23
6.32
4.0
2.1
mmol/l
2.3
2.3
0.04
64
351
(3013115) Eosinophils [#/volume] in Blood
100
648
2.17
6.29
7.3
5.3
e9/l
0.2
0.2
2.08
87
551
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
19
53
3.88
6.22
1.8
2.0
ug/l
3.1
2.5
0.12
13
43
(3002030) Lymphocytes/100 leukocytes in Blood
93
589
2.15
6.17
7.5
5.6
%
25.5
27.0
0.41
86
534
(3022096) Basophils/100 leukocytes in Blood
90
563
2.15
6.16
6.7
5.4
%
0.7
0.7
0.21
84
514
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
19
54
3.80
6.06
3.1
2.0
ug/l
262.3
443.9
0.60
19
47
(3006504) Eosinophils/100 leukocytes in Blood
91
575
2.13
6.04
7.4
5.4
%
2.3
3.1
3.61
85
522
(3018010) Neutrophils/100 leukocytes in Blood
92
585
2.13
5.99
7.3
5.3
%
58.7
57.7
0.25
86
535
(3019069) Monocytes/100 leukocytes in Blood
91
578
2.12
5.93
8.2
5.7
%
8.5
8.9
0.64
85
526
(3004789) Transferrin [Mass/volume] in Serum or Plasma
43
200
2.49
5.91
2.7
2.3
g/l
2.3
2.3
0.27
38
182
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
90
3.05
5.56
1.9
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
40
190
2.41
5.22
2.8
2.3
%
17.7
22.1
1.39
30
168
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
42
3.80
4.87
6.0
4.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
33
150
2.46
4.72
1.2
1.3
titre
537.1
447.0
—
7
40
(3023520) Reticulocytes [#/volume] in Blood
32
144
2.47
4.67
2.1
2.1
e9/l
73.3
64.5
0.78
19
116
(3001122) Ferritin [Mass/volume] in Serum or Plasma
79
515
1.92
4.47
3.5
2.7
ug/l
123.3
136.2
0.28
73
465
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
241
2.14
4.39
2.4
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
6
12.05
4.31
8.6
1.7
nmol/l
4.0
5.9
—
7
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
6
12.05
4.31
2.3
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
42
3.52
4.13
1.7
2.1
u/ml
0.2
0.3
—
6
20
(40758558) Short blood count panel - Blood
49
279
2.02
4.04
9.2
4.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
74
486
1.86
4.00
3.6
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
95
2.62
3.99
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
174
2.17
3.69
10.4
9.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
112
2.42
3.68
1.6
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
77
524
1.80
3.64
4.1
3.2
ng/l
1847.8
1901.1
0.04
66
437
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
169
2.16
3.57
2.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
27
127
2.32
3.57
1.4
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
164
2.15
3.45
2.3
2.6
ug/l
3.2
6.2
2.28
25
140
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
239
1.98
3.44
2.7
2.6
e6/l
0.5
1.2
2.25
28
139
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
65
2.78
3.41
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
10
7.22
3.39
1.7
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
21
90
2.50
3.39
5.0
3.1
e9/l
6.6
3.7
1.03
14
61
(3013707) Erythrocyte sedimentation rate by Westergren method
124
986
1.76
3.29
5.3
4.0
mm/h
17.4
12.6
1.98
119
882
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
168
2.09
3.25
2.0
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
11
6.56
3.21
1.7
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
11
6.56
3.21
1.7
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
11
6.56
3.21
1.7
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
11
6.56
3.21
1.7
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
11
6.56
3.21
1.7
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
23
439
0.46
3.17
3.3
3.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
45
3.03
3.09
1.2
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
16
5.17
3.08
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
75
529
1.70
3.01
2.6
2.2
nmol/l
79.4
75.5
0.59
64
455
(40768441) Liver Pathology biopsy report
5
5
10.22
2.99
1.0
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
103
2.29
2.94
1.6
1.4
—
—
—
0
0
(4024509)
6
9
6.84
2.89
2.0
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
55
360
1.75
2.87
3.7
2.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
18
4.59
2.83
1.4
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
38
224
1.87
2.78
1.7
1.7
s
29.4
29.4
0.01
38
214
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
15
4.80
2.62
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
30
167
1.95
2.60
1.8
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
26
3.58
2.51
1.8
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
82
614
1.60
2.50
5.1
4.2
ng/l
39.5
49.1
0.36
66
470
(3026008) Bacteria identified in Urine by Culture
57
390
1.66
2.50
3.8
3.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
112
2.09
2.42
5.8
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
12
5.13
2.42
2.5
4.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
56
385
1.65
2.40
3.7
2.8
e6/l
0.3
0.4
0.39
44
282
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
293
1.71
2.36
1.6
1.6
mg/l
1.4
1.3
0.11
37
218
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
28
3.32
2.34
1.8
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
28
3.32
2.34
1.7
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
29
3.21
2.26
2.3
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
58
410
1.60
2.21
3.8
3.0
e6/l
86.1
250.0
0.49
48
314
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
19
95
2.11
2.19
2.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
75
2.24
2.15
5.8
3.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
309
1.65
2.14
5.1
3.6
ng/l
155.7
136.9
0.07
40
254
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
219
1.74
2.11
3.0
2.9
e6/l
1.1
2.0
0.72
21
119
(3019225) pH of Specimen
23
126
1.94
2.09
6.5
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
113
935
1.53
2.09
3.3
3.6
pmol/l
14.8
15.1
0.58
103
829
(3018418) pH of Serum or Plasma
56
402
1.56
1.97
3.1
3.1
ph
7.4
7.4
—
5
63
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
11
4.64
1.95
1.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
107
1.97
1.95
3.8
2.1
ml/min/173m2
69.1
61.5
—
8
44
(3018095) Leukocytes [#/volume] in Urine
64
475
1.53
1.94
4.2
3.5
e6/l
73.0
94.2
0.21
48
339
(3019309) Folate [Moles/volume] in Red Blood Cells
47
325
1.60
1.94
1.7
1.8
nmol/l
1164.8
1171.5
0.02
34
254
(40760888) Immunoglobulin light chains.free panel - Serum
8
28
2.94
1.88
3.7
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
43
293
1.61
1.88
1.2
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
40
2.58
1.87
2.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
40
2.58
1.87
1.5
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
7
23
3.12
1.81
1.3
1.2
u/ml
20.7
15.2
—
7
23
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
36
2.57
1.76
1.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
24
2.99
1.74
1.6
1.1
—
—
—
0
0
(3012544) pH of Venous blood
24
143
1.78
1.71
3.7
3.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
42
2.46
1.71
3.2
1.4
—
1.3
—
0
5
(3009343) pH of Capillary blood
19
105
1.90
1.70
5.8
3.1
—
7.4
—
0
10
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
10
43
2.40
1.63
3.3
1.3
mg/l
23.4
36.3
—
10
36
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
26
2.76
1.59
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
20
3.06
1.59
2.8
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
20
3.06
1.59
2.0
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
148
1331
1.54
1.58
32.8
13.7
mg/l
33.6
24.5
2.10
135
1045
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
64
2.11
1.58
1.0
1.3
g/l
4.2
3.9
—
7
46
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
64
2.11
1.58
1.0
1.3
g/l
8.0
7.6
—
7
49
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
64
2.11
1.58
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
124
1.78
1.55
3.1
3.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
27
2.65
1.53
3.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
27
2.65
1.53
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
27
2.65
1.53
1.4
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
21
2.92
1.52
1.0
4.2
—
37.3
—
0
7
(3007853) Bacteria identified in Skin by Aerobe culture
25
157
1.68
1.50
2.7
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
22
2.78
1.44
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
22
2.78
1.44
1.3
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
60
2.07
1.41
3.2
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
60
2.07
1.41
1.4
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
185
1.60
1.39
4.6
4.8
%
30.6
31.1
0.08
16
123
(4010399)
17
98
1.81
1.36
1.8
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
42
2.20
1.35
1.3
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
41
299
1.48
1.32
3.9
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
82
681
1.36
1.27
2.9
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
49
2.10
1.24
1.8
1.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
65
1.90
1.16
1.0
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
7
30
2.38
1.13
3.3
1.7
umol/l
25.0
31.0
—
7
23
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
31
2.31
1.11
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
105
1.68
1.10
3.1
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
41
1.99
1.10
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
21
2.42
1.09
1.2
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
21
2.42
1.09
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
82
1.76
1.08
2.1
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
52
1.98
1.08
2.9
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
132
1196
1.35
1.08
4.7
4.4
mu/l
2.1
2.0
0.42
120
1057
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
22
2.31
1.04
5.0
2.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
10
54
1.90
0.98
1.5
1.9
—
132.0
—
0
5
(3020891) Body temperature
12
70
1.76
0.95
5.8
3.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
28
2.18
0.92
1.0
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
104
923
1.29
0.92
5.7
4.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
57
468
1.31
0.91
3.5
3.4
mg/l
993.0
414.8
0.26
40
312
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
29
2.10
0.90
1.7
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
56
1.83
0.89
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
60
499
1.30
0.87
3.8
4.2
mg/mmol
5.9
8.8
0.59
44
327
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
57
1.80
0.85
1.2
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
31
1.97
0.85
1.5
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
48
389
1.31
0.84
2.9
2.6
umol/l
19155.8
9532.7
0.32
42
338
(3000330) Specific gravity of Urine by Test strip
13
81
1.65
0.83
2.8
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
150
0.58
0.83
3.0
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
28
209
1.40
0.82
1.4
1.3
g/l
3.0
2.9
0.06
15
124
(3009508) Creatinine [Moles/volume] in Urine
57
478
1.28
0.77
3.4
3.2
mmol/l
7.1
7.6
0.34
49
400
(3001019) Free T4 and TSH panel - Serum or Plasma
0
28
0.00
0.76
0.0
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
58
1.58
0.71
1.3
1.3
u/ml
73.8
263.4
—
9
52
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
41
1.73
0.70
1.0
1.2
g/l
0.0
0.0
—
7
41
(3041096) Erythrocytes [Presence] in Urine by Automated
27
346
0.74
0.69
3.6
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
27
1.87
0.69
1.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
126
1168
1.24
0.67
34.3
14.7
%
35.6
40.0
3.05
79
740
(36660697) Celiac disease serology panel - Serum
13
87
1.53
0.65
1.8
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
29
1.74
0.64
2.0
2.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
29
1.74
0.64
1.4
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
50
1.63
0.62
1.1
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
65
573
1.21
0.55
11.4
8.5
e9/l
0.0
0.0
0.74
49
460
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
555
1.20
0.54
3.5
3.7
%
16.9
24.9
3.33
22
262
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
99
0.59
0.53
1.8
1.3
—
—
—
0
0
(3015736) pH of Urine
57
498
1.21
0.53
4.0
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
137
1.35
0.49
1.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
131
1239
1.19
0.48
27.7
12.7
ml/min/173m2
72.7
74.4
0.39
118
997
(3049717) Cytology report of Urine Cyto stain
7
49
1.44
0.46
2.6
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
31
1.63
0.43
3.2
2.2
pmol/l
182.2
231.4
—
5
26
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
373
1.20
0.43
1.8
2.6
ug/l
0.7
0.8
0.37
25
257
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
33
1.53
0.41
1.0
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
34
1.48
0.40
1.8
3.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
18
0.00
0.40
0.0
2.0
—
457.8
—
0
10
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
18
0.00
0.40
0.0
2.3
—
34.6
—
0
18
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
9
66
1.38
0.39
2.2
3.9
mmol/l
24.2
24.8
—
9
59
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
90
1.36
0.37
2.8
2.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
42
1.44
0.36
1.8
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
132
1263
1.15
0.35
7.6
6.6
mmol/mol
42.4
41.3
0.70
120
1157
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
28
240
1.20
0.32
1.6
1.2
u/ml
0.7
1.6
—
8
61
(40761511) CBC panel - Blood by Automated count
144
1390
1.16
0.32
27.6
13.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
706
1.13
0.31
5.5
3.9
ug/l
1.7
2.1
0.64
70
626
(3020564) Creatinine [Moles/volume] in Serum or Plasma
146
1413
1.15
0.30
37.8
16.2
umol/l
85.4
84.1
0.21
146
1413
(3017181) Myelocytes/100 leukocytes in Blood
12
94
1.30
0.29
3.3
4.7
%
3.2
0.8
—
5
26
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
128
1327
0.89
0.28
5.6
5.0
mmol/l
6.3
6.1
0.63
119
1183
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
63
1.28
0.28
1.5
2.6
pmol/l
4.0
4.2
—
8
54
(3029937) Albumin [Presence] in Urine by Test strip
31
348
0.87
0.25
4.4
4.1
estimate
0.0
0.0
—
6
96
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
82
0.72
0.24
1.3
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
103
1075
0.91
0.24
39.8
16.1
%
14.3
13.8
2.74
103
1046
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
38
1.32
0.23
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
68
640
1.10
0.21
4.1
3.8
estimate
0.0
0.0
—
6
96
(3045142) Bone marrow Pathology biopsy report
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
0
12
0.00
0.21
0.0
1.9
—
485.9
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
137
1.18
0.19
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
339
1.11
0.19
1.5
1.8
pmol/l
566.2
419.3
0.46
27
273
(4034850)
7
59
1.19
0.18
9.0
11.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
82
1.23
0.17
1.5
1.2
—
42.3
—
0
8
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
22
199
1.12
0.14
1.3
1.3
u/ml
2.0
14.3
—
5
67
(3035350) Ketones [Presence] in Urine by Test strip
66
634
1.06
0.12
4.0
3.8
estimate
0.0
0.0
—
6
105
(3044889) 12 lead EKG panel
100
976
1.05
0.10
5.2
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
48
498
0.95
0.07
4.3
4.0
—
—
—
0
0
(3000492) Spirometry study
12
108
1.12
0.07
1.2
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
65
632
1.04
0.07
5.6
5.1
estimate
0.0
0.0
—
6
103
(40760892) CBC W Ordered Manual Differential panel - Blood
27
258
1.05
0.05
6.7
4.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
129
1302
0.97
0.04
4.8
4.8
mmol/l
1.4
1.4
0.35
119
1172
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
127
1263
1.02
0.01
4.3
4.3
mmol/l
1.4
1.3
0.74
116
1126
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
22
216
1.02
0.00
1.3
1.3
iu/ml
30.9
33.2
—
8
70
(3013512) EKG study
45
449
1.00
0.00
6.9
4.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
135
1349
1.00
0.00
5.3
5.4
mmol/l
2.3
2.6
2.50
126
1218
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
131
1312
0.99
0.00
4.8
4.8
mmol/l
4.2
4.4
1.47
121
1189
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
2.3
—
2393.8
—
0
8
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
90.7
—
0
5
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
0.1
—
0
7
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
49
1.02
0.00
1.2
1.0
—
—
—
0
0
(4015189)
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
247.8
—
0
9
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
70
1.00
0.00
1.3
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ORAL_EXALLC – Carcinoma in situ of oral cavity, oesophagus and stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).